StockNews.AI
AVNS
StockNews.AI
14 days

Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors

1. Scott Galovan appointed CFO, effective Aug. 1, 2025. 2. Galovan has 12 years of experience at Avanos. 3. His leadership will drive strategic partnerships and long-term planning. 4. David Pacitti also joins the board of directors on Aug. 1, 2025. 5. Avanos focuses on improving patient care and reducing opioid use.

5m saved
Insight
Article

FAQ

Why Bullish?

The appointment of a seasoned CFO signals strategic growth and stability, enhancing investor confidence. Historical data shows similar leadership changes often correlate with improved stock performance.

How important is it?

The CFO's appointment may significantly influence Avanos's strategic direction and financial health, impacting investor sentiment and stock price.

Why Long Term?

New leadership can reshape company strategy effectively over time. Historical examples indicate such changes often take time to translate into significant market performance.

Related Companies

AVNSPBHBAXMDTSYK
, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025. Galovan most recently served as Avanos' senior vice president of strategy and corporate development. His background with the company spans 12 years and is highlighted by a proven track record of leading a number of acquisition and divestiture initiatives. Prior to Avanos, he spent 10 years in a variety of strategy, finance, and M&A roles for Newell Brands, Equity Pacific Partners, and Intel Capital. As CFO, Galovan will oversee the company's global finance, treasury, tax, corporate development, investor relations, and accounting groups, as well as its Enterprise Program Management Office. He will report directly to David Pacitti, Avanos chief executive officer. "Scott brings a growth-oriented mindset to the CFO role, which will be critical as we look to build on the significant progress we've made with our transformation efforts," said Pacitti. "His ability to drive strategic partnerships, coupled with his deep understanding of market dynamics, will help to shape our next chapter, enhance our long-term planning, and maintain a sharp focus on shareholder value." Galovan earned a bachelor's degree from BYU and a master's of business administration from the University of California at Los Angeles, where he was a Venture Fellow. The Company also announced the appointment of Pacitti as a member of its board of directors, effective Aug. 1, 2025. "On behalf of the entire board, I am pleased to welcome Dave to the Avanos board," said Gary Blackford, Avanos board chair. "His extensive industry experience and leadership will further strengthen the Company's vision of being the best at getting patients back to the things that matter." About Avanos MedicalAvanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook. SOURCE Avanos Medical WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News